The two companies have worked together for more than a decade, with IBM unveiling what it described as the world's first 2nm node chip in 2021 as part of the partnership.

Imaging-based single-cell physiological profiling holds great potential for uncovering fundamental bacterial cold shock response (CSR) mechanisms, but its application is impeded by severe focus drift ...